Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537751) titled 'Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis' on April 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Noura Abdelmoneim Mohammed Elseessy
Condition:
Atopic Dermatitis
Eczema
Intervention:
Drug: Crisaborole 2% topical ointment
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 1, 2024
Target Sample Size: 40
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/...